« Back to Record
Citation APA

Schöffski, P., Machiels, J. P., Rottey, S., Sadrolhefazi, B., Musa, H., Marzin, K., & Awada, A. (2023). Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours. European journal of cancer, 191, 112987. doi:10.1016/j.ejca.2023.112987


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371565

Schöffski, P., Machiels, J. P., Rottey, S., Sadrolhefazi, B., Musa, H., Marzin, K., & Awada, A. (2023). Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours. European journal of cancer, 191, 112987. doi:10.1016/j.ejca.2023.112987